Ozempic, Wegovy prices to drop up to 50% as Novo Nordisk's rivalry with Eli Lilly heats up: report

Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by as much as 50%, according to a report.Starting next January, Wegovy and Ozempic will each list for $675 a month – half of Wegovy’s current price tag and a 34% drop for Ozempic, the Wall Street Journal reported Tuesday.Pill versions of both drugs, including a version known as Rybelsus, will also see the price cuts, according to the report.Drugmaker Novo Nordisk plans to slash list pri ...